Cargando…

Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection

OBJECTIVE: The study aimed to evaluate the prevalence and predictor factors for compensated advanced chronic liver disease (c-ACLD) in patients with hepatitis Delta virus (HDV) infection. METHODS: This cross-sectional study included consecutive HDV-infected patients defined by positive anti-HDV. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Couto, Ingrid, Victoria, Marilu, Veloso, Valdiléa G., Rodrigues, Lorena, Grinsztejn, Beatriz, Lacerda, Marcus, Victoria, Flamir, Perazzo, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362235/ https://www.ncbi.nlm.nih.gov/pubmed/28329027 http://dx.doi.org/10.1371/journal.pone.0174453

Ejemplares similares

Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
por: Castro, Rodolfo, et al.
Publicado: (2015)

Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography
por: Perazzo, Hugo, et al.
Publicado: (2015)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
por: Castro, Rodolfo, et al.
Publicado: (2020)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
por: Netter, Hans J., et al.
Publicado: (2021)

ACLD patients exhibit additional knee kinematic asymmetries at the speed level of healthy subjects
por: Kong, Lingchuang, et al.
Publicado: (2022)

Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures
por: Ghamari, Shiva, et al.
Publicado: (2013)

High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta
por: Romeo, Raffaella, et al.
Publicado: (2014)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis
por: Chen, Sisi, et al.
Publicado: (2023)

Management of Delta Hepatitis 45 Years after the Discovery of HDV
por: Brillanti, Stefano
Publicado: (2022)

COVID-19: An Overview of Worldwide Recommendations for Management of Patients With Liver Diseases or Liver Transplantation
por: Perazzo, Hugo, et al.
Publicado: (2020)

Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis
por: Castro, Rodolfo, et al.
Publicado: (2020)

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
por: Wranke, Anika, et al.
Publicado: (2014)

Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
por: Perazzo, Hugo, et al.
Publicado: (2020)

Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges
por: Veloso, Valdilea G, et al.
Publicado: (2015)

2198. Increased Global Incidence and Altered Demographic Profile of Hepatitis Delta Virus (HDV)
por: Weller, Melodie, et al.
Publicado: (2018)

HDV-Like Viruses
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)

Age-standardized mortality rates related to viral hepatitis in Brazil
por: Perazzo, Hugo, et al.
Publicado: (2017)

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention
por: Luz, Paula M., et al.
Publicado: (2019)

Hepatitis of unknown etiology in children in Brazil: A new challenge or the usual scenario ?
por: Castro, Rodolfo, et al.
Publicado: (2022)

AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis (†)
por: Maestro, Sheila, et al.
Publicado: (2021)

Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype
por: Mello, Francisco C. A., et al.
Publicado: (2023)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Combination of Novel Therapies for HDV
por: Elazar, Menashe, et al.
Publicado: (2022)

A Review of HDV Infection
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype
por: Dziri, Samira, et al.
Publicado: (2021)

Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review
por: Coelho, Lara, et al.
Publicado: (2013)

Molecular epidemiology and clinical characteristics of hepatitis delta virus (HDV) infected patients with elevated transaminases in Shanghai, China
por: Wu, Shanshan, et al.
Publicado: (2020)

HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy
por: Mangia, Alessandra, et al.
Publicado: (2023)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses
por: Castro, Rodolfo, et al.
Publicado: (2018)

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy
por: Perazzo, Hugo, et al.
Publicado: (2018)

HDV infection rates in northern Vietnam
por: Binh, Mai Thanh, et al.
Publicado: (2018)

HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021)

HDV Pathogenesis: Unravelling Ariadne’s Thread
por: Tseligka, Eirini D., et al.
Publicado: (2021)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
por: Piedade, Juliana, et al.
Publicado: (2021)

Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
por: Rodrigues, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ovkh88jg66o2iilp9ljc4voaro